Qianlieping capsule plus alpha-blocker for chronic non-bacterial prostatitis: analysis of 220 cases.
- Author:
Jian-Ping LI
1
;
Tie CHONG
;
Hai-Wen CHEN
;
He-Cheng LI
;
Jun CAO
;
Peng ZHANG
;
Hong-Liang LI
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adrenergic alpha-Antagonists; administration & dosage; therapeutic use; Adult; Capsules; Chronic Disease; Drugs, Chinese Herbal; administration & dosage; therapeutic use; Humans; Male; Phytotherapy; Prostatitis; drug therapy; Sulfonamides; administration & dosage; therapeutic use; Treatment Outcome; Young Adult
- From: National Journal of Andrology 2012;18(9):856-858
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the clinical effects of Qianlieping Capsule combined with alpha-receptor blocker tamsulosin on chronic non-bacterial prostatitis (CNBP).
METHODSWe assigned 220 CNBP patients to three groups to receive oral Qianlieping Capsule (2.0 g tid) plus alpha-receptor blocker tamsulosin (0.2 mg qd) (n = 98), Qianlieping Capsule alone at 2.0 g tid (n = 66), and tamsulosin alone at 0.2 mg qd (n = 56) , respectively. After 6 weeks of medication, we assessed the therapeutic effects according to the NIH-CPSI scores and the number of small particles of lecithin (SPL) in the prostatic fluid after treatment.
RESULTSQianlieping Capsule alone increased the number of SPL by 46.9% and reduced the NIH-CPSI score by 24.4%. Combination of Qianlieping and tamsulosin more significantly increased the number of SPL (61.4%) and decreased the NIH-CPSI score (42.3%) than tamsulosin alone (33.7% and 28.6%) (P < 0.01).
CONCLUSIONQianlieping Capsule chronic is effective for chronic non-bacterial prostatitis, and the combination of Qianlieping Capsule with tamsulosin produces even better effect than tamsulosin alone.
